Advertisement
open access
Medical Conferences
Conference Reports
Conference Proceedings
Disease Areas
Medical News
Multimedia
Podcast Channel
Videos
Webinar
About
2024 Medicom Conference Planning
Conference Proceedings
Home
>
Cardiology
>
AHA 2019
AHA 2019
American Heart Association 16–18 November 2019 Philadelphia, USA
Read the full Report (e-book)
Table of Contents
Colophon
Table of Contents
Featured articles
Introduction to the AHA 2019 Conference Report
Editor Biography
Editor
Dr Marc P. Bonaca, University of Colorado
New Approaches to CVD Risk Reduction
Phase 3 BETonMACE trial did not meet its primary endpoint
Presented By
Prof. Kausik K. Ray, Imperial College London, United Kingdom
Inclisiran safely halves LDL-Cholesterol
Presented By
Prof. R. Scott Wright, Mayo Clinic, Rochester, USA
Colchicine prevents cardiovascular events
Presented By
Prof. Jean-Claude Tardif, University of Montreal, Canada
Interventional Management for Acute Coronary Syndrome
Drop aspirin after 3 months in non-STEMI ACS patients on dual antiplatelet therapy
Presented By
Prof. Usman Baber, Icahn School of Medicine at Mount Sinai, USA
Immediate coronary angiography after cardiac arrest does not improve survival
Presented By
Dr Jorrit Lemkes, Amsterdam University Medical Center, the Netherlands
Complete revascularisation for obstructive non-culprit lesions with vulnerable plaque
Presented By
Dr Natalia Pinilla-Echeverri, McMaster University, Canada
Colchicine: no difference in peri-procedural cardiovascular events 30 days post-PCI
Presented By
Dr Binita Shah, NYU School of Medicine, USA
Intra-aortic balloon pump better than Impella: new observational data
Presented By
Dr Sanket S. Dhruva, University of California, San Francisco, USA
Results for the Ischemia Trials: To Intervene or Not to Intervene
ISCHEMIA trial: Invasive treatment only better for angina burden
Presented By
Prof. Judith Hochman, New York University School of Medicine, USA
Controversies in Contemporary Management of Aortic Stenosis
Full GALILEO results: Why did rivaroxaban fail after TAVR?
Presented By
Prof. George Dangas, Icahn School of Medicine at Mount Sinai, USA
Balloon-expandable better than self-expanding transcatheter heart valves
Presented By
Dr Eric Van Belle, CHU Lille, France
RECOVERY: Benefit of early surgery in asymptomatic severe aortic stenosis
Presented By
Prof. Duk-Hyun Kang, Asan Medical Center, South Korea
Guidelines: Updates and Controversies
New guidelines on the prevention of cardiovascular conditions
Presented By
Prof. Roger S. Blumenthal, Johns Hopkins University, USA
Trials in Electrophysiology and Left Ventricular Function
RENAL-AF trial: Apixaban similar to warfarin
Presented By
Dr Sean Pokorney, Duke Clinical Research Institute, USA
Apple Heart Study: Not just for atrial fibrillation
Presented By
Prof. Marco Perez, Stanford University, USA
Early apixaban safe as secondary prevention of stroke from AF
Presented By
Dr Arthur Labovitz, University of South Florida, USA
Carvedilol does not improve exercise performance in Fontan patients
Presented By
Dr Ryan Butts, University of Texas Southwestern, Dallas, USA
Testosterone gel increases left ventricular mass
Presented By
Dr Elizabeth Hutchins, UCLA, USA
New Frontiers in Lipid Therapy
Icosapent ethyl plus statins reduces total plaque volume
Presented By
Prof. Matthew J. Budoff, UCLA, USA
ORION-9: Inclisiran RNAi halves LDL in familial hypercholesterolaemia patients
Presented By
Prof. Frederick Raal, University of the Witwatersrand, South Africa
New RNAi therapies to reduce triglycerides: 2 studies show favourable results
Presented By
Prof. Christie Ballantyne & Prof. Gerald Watts
Targeting LDL-C <70 mg/dL is better than 100 mg/dL after stroke
Presented By
Prof. Pierre Amarenco, Xavier Bichat Medical School and Denis Diderot University, France
Challenges in Heart Failure Management
FUEL trial: Udenafil improves some exercise measurements in Fontan
Presented By
Dr David Goldberg, Children’s Hospital of Philadelphia, USA
DAPA-HF: Dapagliflozin also good for heart failure patients without diabetes, of any age, or any health status
Presented By
Prof. John J. McMurray & Prof. Felipe A. Martinez
PARAGON-HF: Benefits for women and lower ejection fraction
Expert
Prof. Scott D. Solomon & Prof. Lynne W. Stevenson